China SXT Pharmaceuticals, Inc.
SXTC
$0.09
-$0.01-5.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.18M | -3.18M | -1.25M | -1.25M | -401.30K |
| Total Depreciation and Amortization | 16.10K | 16.10K | 6.90K | 6.90K | 34.30K |
| Total Amortization of Deferred Charges | -- | -- | 216.20K | 216.20K | 44.20K |
| Total Other Non-Cash Items | 2.79M | 2.79M | 646.10K | 646.10K | 17.40K |
| Change in Net Operating Assets | -496.30K | -496.30K | -112.70K | -112.70K | -373.20K |
| Cash from Operations | -876.30K | -876.30K | -494.10K | -494.10K | -678.60K |
| Capital Expenditure | -- | -- | -1.00K | -1.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 12.50K | 12.50K | 20.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -462.30K | -462.30K | -- | -- | -- |
| Cash from Investing | -462.30K | -462.30K | 11.50K | 11.50K | 20.30K |
| Total Debt Issued | 153.50K | 153.50K | 154.70K | 154.70K | 3.69M |
| Total Debt Repaid | -57.70K | -57.70K | -919.90K | -919.90K | -39.10K |
| Issuance of Common Stock | 2.59M | 2.59M | 1.38M | 1.38M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -33.80K | -33.80K | -33.80K |
| Cash from Financing | 2.69M | 2.69M | 581.00K | 581.00K | 3.62M |
| Foreign Exchange rate Adjustments | 187.10K | 187.10K | -290.10K | -290.10K | 257.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.53M | 1.53M | -191.70K | -191.70K | 3.22M |